E. Lynne Kelley, M.D., FACS
2019
In 2019, E. Lynne Kelley, M.D., FACS earned a total compensation of $970K as Former Chief Medical Officer at X4 Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $121,005 |
|---|---|
| Option Awards | $566,374 |
| Salary | $280,968 |
| Other | $1,604 |
| Total | $969,951 |
FACS received $566.4K in option awards, accounting for 58% of the total pay in 2019.
FACS also received $121K in non-equity incentive plan, $281K in salary and $1.6K in other compensation.
Rankings
In 2019, E. Lynne Kelley, M.D., FACS' compensation ranked 9,403rd out of 13,971 executives tracked by ExecPay. In other words, FACS earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,403 out of 13,971 | 33rd |
Division Manufacturing | 3,775 out of 5,698 | 34th |
Major group Chemicals And Allied Products | 1,434 out of 2,197 | 35th |
Industry group Drugs | 1,223 out of 1,883 | 35th |
Industry Biological Products, Except Diagnostic Substances | 272 out of 389 | 30th |
Source: SEC filing on April 28, 2020.
FACS' colleagues
We found three more compensation records of executives who worked with E. Lynne Kelley, M.D., FACS at X4 Pharmaceuticals in 2019.